DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OCTREOTIDE ACETATE

« Back to Dashboard

Clinical Trials for Octreotide Acetate

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00003057	Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer	Completed	Cancer and Leukemia Group B	Phase 3	RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
NCT00003057	Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer	Completed	National Cancer Institute (NCI)	Phase 3	RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
NCT00003057	Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer	Completed	Southwest Oncology Group	Phase 3	RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
NCT00003057	Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer	Completed	Eastern Cooperative Oncology Group	Phase 3	RATIONALE: Drugs such as octreotide and loperamide hydrochloride use different ways to relieve the diarrhea caused by chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of octreotide with loperamide hydrochloride for the treatment of chemotherapy-related diarrhea in patients who have colorectal cancer.
NCT00008073	Octreotide and Doxorubicin in Treating Patients With Advanced Cancer	Completed	National Cancer Institute (NCI)	Phase 1	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Octreotide may help doxorubicin kill more cancer cells by making tumor cells more sensitive to the drug. PURPOSE: Phase I trial to study the effectiveness of octreotide and doxorubicin in treating patients who have advanced cancer.

Clinical Trial Conditions for Octreotide Acetate

Condition Name

Condition Name for Octreotide Acetate
Intervention	Trials
Acromegaly	9
Diabetic Retinopathy	4
Islet Cell Tumor	2
Diarrhea	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Octreotide Acetate
Intervention	Trials
Acromegaly	9
Carcinoid Tumor	5
Neuroendocrine Tumors	5
Retinal Diseases	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Octreotide Acetate

Trials by Country

Trials by Country for Octreotide Acetate
Location	Trials
United States	172
Canada	5
Serbia	3
Romania	3
Ukraine	3

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Octreotide Acetate
Location	Trials
California	7
New Jersey	6
Ohio	6
Tennessee	5
Minnesota	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Octreotide Acetate

Clinical Trial Phase

Clinical Trial Phase for Octreotide Acetate
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	12
Phase 2	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Octreotide Acetate
Clinical Trial Phase	Trials
Completed	18
Terminated	6
Active, not recruiting	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Octreotide Acetate

Sponsor Name

Sponsor Name for Octreotide Acetate
Sponsor	Trials
National Cancer Institute (NCI)	10
Novartis Pharmaceuticals	6
Novartis	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Octreotide Acetate
Sponsor	Trials
Industry	19
Other	10
NIH	10

Export unavailable in trial.
Subscribe for complete access.